Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37638324 | PubTator, text mining | PubMed |
| Late Diagnosis of Primary Hyperoxaluria in an Adult Patient With End-Stage Renal Disease and Bicytopenia. | Cureus | 2023 | 37637636 | PubTator, text mining | PubMed |
| The relationship of tongue fat content and efficacy of uvulopalatopharyngoplasty in Chinese patients with obstructive sleep apnea. | BMC Surg | 2023 | 37635206 | PubTator, text mining | PubMed |
| The Resistance to Lethal Challenge with Ostreid herpesvirus-1 of Pacific Oysters (Crassostrea gigas) Previously Exposed to This Virus. | Viruses | 2023 | 37632048 | PubTator, text mining | PubMed |
| Idiopathic Oxalate Nephropathy Leading to End-Stage Kidney Disease: A Case Report. | Cureus | 2023 | 37621792 | PubTator, text mining | PubMed |
| Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer. | Transl Oncol | 2023 | 37619523 | PubTator, text mining | PubMed |
| The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications. | J Mol Med (Berl) | 2023 | 37584739 | PubTator, text mining | PubMed |
| Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2023 | 37581107 | PubTator, text mining | PubMed |
| Linoleic Acid Induced Changes in SZ95 Sebocytes-Comparison with Palmitic Acid and Arachidonic Acid. | Nutrients | 2023 | 37571253 | PubTator, text mining | PubMed |
| Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice? | Int J Mol Sci | 2023 | 37569827 | PubTator, text mining | PubMed |
| Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events. | Blood Cancer J | 2023 | 37567878 | PubTator, text mining | PubMed |
| Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19. | Cells | 2023 | 37566018 | PubTator, text mining | PubMed |
| Structure transformation from Sierpiński triangles to chains assisted by gas molecules. | Natl Sci Rev | 2023 | 37564921 | PubTator, text mining | PubMed |
| Joint manifestations revealing inborn metabolic diseases in adults: a narrative review. | Orphanet J Rare Dis | 2023 | 37563694 | PubTator, text mining | PubMed |
| Mitochondrial evolution: Gene shuffling, endosymbiosis, and signaling. | Sci Adv | 2023 | 37556561 | PubTator, text mining | PubMed |
| A bacterial enzyme may correct 2-HG accumulation in human cancers. | Front Oncol | 2023 | 37546420 | PubTator, text mining | PubMed |
| Ceramides Increase Fatty Acid Utilization in Intestinal Progenitors to Enhance Stemness and Increase Tumor Risk. | Gastroenterology | 2023 | 37541526 | PubTator, text mining | PubMed |
| Dual-reactive hydrogels functionalizable using "Huisgen click" and "Schiff base" reactions. | Turk J Chem | 2023 | 37529222 | PubTator, text mining | PubMed |
| Primary Hyperoxaluria Type 1: Clinical, Paraclinical, and Evolutionary Aspects in Adults from One Nephrology Center. | Int J Nephrol | 2023 | 37521011 | PubTator, text mining | PubMed |
| The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review. | Nutrients | 2023 | 37513540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=19